Owlet, Inc. (NYSE: OWLT) Stock Competitors & Peer Comparison
See OWLT's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for OWLT and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OWLT | $4.63 | +0.22% | 83.6M | -33.00 | -$0.14 | N/A |
| ABT | $102.61 | +0.78% | 177.7B | 19.71 | $5.21 | +2.44% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $93.01 | +1.17% | 119B | 16.81 | $5.53 | +3.13% |
| SYK | $282.55 | -0.02% | 108.3B | 21.11 | $13.39 | +1.25% |
| BSX | $43.31 | -1.21% | 64.4B | 13.97 | $3.10 | N/A |
| EW | $85.27 | -1.30% | 49.1B | 31.58 | $2.70 | N/A |
| DXCM | $85.06 | -1.00% | 32.1B | 33.36 | $2.55 | N/A |
| GEHC | $68.79 | +1.55% | 31.1B | 15.09 | $4.56 | +0.21% |
| PHG | $24.89 | +0.61% | 24.3B | 14.22 | $1.75 | +4.01% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
OWLT vs ABT Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, ABT has a market cap of 177.7B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while ABT trades at $102.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas ABT's P/E ratio is 19.71. In terms of profitability, OWLT's ROE is -0.50%, compared to ABT's ROE of +0.11%. Regarding short-term risk, OWLT is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
OWLT vs BSX-PA Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, OWLT's ROE is -0.50%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, OWLT is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BSX-PA's competition here
Medtronic Plc (NYSE: MDT)
OWLT vs MDT Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, MDT has a market cap of 119B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while MDT trades at $93.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas MDT's P/E ratio is 16.81. In terms of profitability, OWLT's ROE is -0.50%, compared to MDT's ROE of +0.11%. Regarding short-term risk, OWLT is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
OWLT vs SYK Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, SYK has a market cap of 108.3B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while SYK trades at $282.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas SYK's P/E ratio is 21.11. In terms of profitability, OWLT's ROE is -0.50%, compared to SYK's ROE of +0.16%. Regarding short-term risk, OWLT is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
OWLT vs BSX Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, BSX has a market cap of 64.4B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while BSX trades at $43.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas BSX's P/E ratio is 13.97. In terms of profitability, OWLT's ROE is -0.50%, compared to BSX's ROE of +0.15%. Regarding short-term risk, OWLT is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
OWLT vs EW Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, EW has a market cap of 49.1B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while EW trades at $85.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas EW's P/E ratio is 31.58. In terms of profitability, OWLT's ROE is -0.50%, compared to EW's ROE of +0.10%. Regarding short-term risk, OWLT is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
OWLT vs DXCM Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, DXCM has a market cap of 32.1B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while DXCM trades at $85.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas DXCM's P/E ratio is 33.36. In terms of profitability, OWLT's ROE is -0.50%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, OWLT is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check DXCM's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
OWLT vs GEHC Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, GEHC has a market cap of 31.1B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while GEHC trades at $68.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas GEHC's P/E ratio is 15.09. In terms of profitability, OWLT's ROE is -0.50%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, OWLT is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
OWLT vs PHG Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, PHG has a market cap of 24.3B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while PHG trades at $24.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas PHG's P/E ratio is 14.22. In terms of profitability, OWLT's ROE is -0.50%, compared to PHG's ROE of +0.10%. Regarding short-term risk, OWLT is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
OWLT vs ZBH Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, ZBH has a market cap of 17.8B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while ZBH trades at $92.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas ZBH's P/E ratio is 10.86. In terms of profitability, OWLT's ROE is -0.50%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, OWLT is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
OWLT vs ABMD Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas ABMD's P/E ratio is 65.36. In terms of profitability, OWLT's ROE is -0.50%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, OWLT is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
OWLT vs PEN Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while PEN trades at $320.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas PEN's P/E ratio is 83.55. In terms of profitability, OWLT's ROE is -0.50%, compared to PEN's ROE of +0.11%. Regarding short-term risk, OWLT is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
OWLT vs SWAV Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas SWAV's P/E ratio is 78.76. In terms of profitability, OWLT's ROE is -0.50%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, OWLT is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
OWLT vs SNN Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, SNN has a market cap of 11.7B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while SNN trades at $27.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas SNN's P/E ratio is 18.81. In terms of profitability, OWLT's ROE is -0.50%, compared to SNN's ROE of +0.12%. Regarding short-term risk, OWLT is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SNN's competition here
Globus Medical, Inc. (NYSE: GMED)
OWLT vs GMED Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, GMED has a market cap of 10.3B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while GMED trades at $76.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas GMED's P/E ratio is 17.19. In terms of profitability, OWLT's ROE is -0.50%, compared to GMED's ROE of +0.12%. Regarding short-term risk, OWLT is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check GMED's competition here
Align Technology, Inc. (NASDAQ: ALGN)
OWLT vs ALGN Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, ALGN has a market cap of 10.3B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while ALGN trades at $143.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas ALGN's P/E ratio is 13.08. In terms of profitability, OWLT's ROE is -0.50%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, OWLT is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
OWLT vs BIO-B Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, BIO-B has a market cap of 9.9B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while BIO-B trades at $362.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas BIO-B's P/E ratio is -63.84. In terms of profitability, OWLT's ROE is -0.50%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, OWLT is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
OWLT vs BIO Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, BIO has a market cap of 9.8B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while BIO trades at $363.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas BIO's P/E ratio is 39.23. In terms of profitability, OWLT's ROE is -0.50%, compared to BIO's ROE of +0.03%. Regarding short-term risk, OWLT is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BIO's competition here
Glaukos Corporation (NYSE: GKOS)
OWLT vs GKOS Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, GKOS has a market cap of 9.8B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while GKOS trades at $165.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas GKOS's P/E ratio is -192.44. In terms of profitability, OWLT's ROE is -0.50%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, OWLT is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
OWLT vs PODD Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, PODD has a market cap of 9.6B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while PODD trades at $138.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas PODD's P/E ratio is 23.53. In terms of profitability, OWLT's ROE is -0.50%, compared to PODD's ROE of +0.27%. Regarding short-term risk, OWLT is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check PODD's competition here
Masimo Corporation (NASDAQ: MASI)
OWLT vs MASI Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas MASI's P/E ratio is 44.43. In terms of profitability, OWLT's ROE is -0.50%, compared to MASI's ROE of +0.09%. Regarding short-term risk, OWLT is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
OWLT vs BRKR Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, BRKR has a market cap of 8.6B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while BRKR trades at $56.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas BRKR's P/E ratio is 28.24. In terms of profitability, OWLT's ROE is -0.50%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, OWLT is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
OWLT vs BRKRP Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, BRKRP has a market cap of 8.4B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while BRKRP trades at $417.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas BRKRP's P/E ratio is 226.68. In terms of profitability, OWLT's ROE is -0.50%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, OWLT is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
OWLT vs HAE Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, HAE has a market cap of 5.5B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while HAE trades at $121.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas HAE's P/E ratio is 24.28. In terms of profitability, OWLT's ROE is -0.50%, compared to HAE's ROE of +0.11%. Regarding short-term risk, OWLT is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check HAE's competition here
Inari Medical, Inc. (NASDAQ: NARI)
OWLT vs NARI Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas NARI's P/E ratio is -59.24. In terms of profitability, OWLT's ROE is -0.50%, compared to NARI's ROE of -0.00%. Regarding short-term risk, OWLT is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
OWLT vs ITGR Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while ITGR trades at $126.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas ITGR's P/E ratio is 19.94. In terms of profitability, OWLT's ROE is -0.50%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, OWLT is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ITGR's competition here
LivaNova PLC (NASDAQ: LIVN)
OWLT vs LIVN Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, LIVN has a market cap of 4.2B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while LIVN trades at $76.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas LIVN's P/E ratio is 18.14. In terms of profitability, OWLT's ROE is -0.50%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, OWLT is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check LIVN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
OWLT vs IRTC Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, IRTC has a market cap of 3.5B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while IRTC trades at $107.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas IRTC's P/E ratio is -250.49. In terms of profitability, OWLT's ROE is -0.50%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, OWLT is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check IRTC's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
OWLT vs TMDX Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, TMDX has a market cap of 2.7B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while TMDX trades at $79.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas TMDX's P/E ratio is 40.17. In terms of profitability, OWLT's ROE is -0.50%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, OWLT is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check TMDX's competition here
Neogen Corporation (NASDAQ: NEOG)
OWLT vs NEOG Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while NEOG trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas NEOG's P/E ratio is 41.89. In terms of profitability, OWLT's ROE is -0.50%, compared to NEOG's ROE of -0.03%. Regarding short-term risk, OWLT is more volatile compared to NEOG. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NEOG's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
OWLT vs UFPT Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while UFPT trades at $294.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas UFPT's P/E ratio is 30.06. In terms of profitability, OWLT's ROE is -0.50%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, OWLT is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
OWLT vs BFLY Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, BFLY has a market cap of 2.2B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while BFLY trades at $8.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas BFLY's P/E ratio is -33.77. In terms of profitability, OWLT's ROE is -0.50%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, OWLT is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check BFLY's competition here
NuVasive, Inc. (NASDAQ: NUVA)
OWLT vs NUVA Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas NUVA's P/E ratio is 75.00. In terms of profitability, OWLT's ROE is -0.50%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, OWLT is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check NUVA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
OWLT vs INSP Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, INSP has a market cap of 2B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while INSP trades at $68.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas INSP's P/E ratio is 30.31. In terms of profitability, OWLT's ROE is -0.50%, compared to INSP's ROE of +0.18%. Regarding short-term risk, OWLT is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check INSP's competition here
AxoGen, Inc. (NASDAQ: AXGN)
OWLT vs AXGN Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, AXGN has a market cap of 1.9B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while AXGN trades at $36.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas AXGN's P/E ratio is 95.18. In terms of profitability, OWLT's ROE is -0.50%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, OWLT is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check AXGN's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
OWLT vs ESTA Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, ESTA has a market cap of 1.7B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while ESTA trades at $58.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas ESTA's P/E ratio is -46.39. In terms of profitability, OWLT's ROE is -0.50%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, OWLT is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check ESTA's competition here
Novocure Ltd (NASDAQ: NVCR)
OWLT vs NVCR Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, NVCR has a market cap of 1.7B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while NVCR trades at $14.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas NVCR's P/E ratio is -11.00. In terms of profitability, OWLT's ROE is -0.50%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, OWLT is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NVCR's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
OWLT vs ATEC Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, ATEC has a market cap of 1.7B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while ATEC trades at $10.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas ATEC's P/E ratio is -180.33. In terms of profitability, OWLT's ROE is -0.50%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, OWLT is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
OWLT vs CNMD Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, CNMD has a market cap of 1.4B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while CNMD trades at $45.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas CNMD's P/E ratio is 10.02. In terms of profitability, OWLT's ROE is -0.50%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, OWLT is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
OWLT vs HSKA Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas HSKA's P/E ratio is -62.49. In terms of profitability, OWLT's ROE is -0.50%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, OWLT is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check HSKA's competition here
Avanos Medical, Inc. (NYSE: AVNS)
OWLT vs AVNS Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas AVNS's P/E ratio is 27.77. In terms of profitability, OWLT's ROE is -0.50%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, OWLT is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check AVNS's competition here
IRadimed Corporation (NASDAQ: IRMD)
OWLT vs IRMD Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while IRMD trades at $89.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas IRMD's P/E ratio is 45.05. In terms of profitability, OWLT's ROE is -0.50%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, OWLT is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check IRMD's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
OWLT vs TNDM Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, TNDM has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while TNDM trades at $16.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas TNDM's P/E ratio is -17.90. In terms of profitability, OWLT's ROE is -0.50%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, OWLT is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check TNDM's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
OWLT vs SILK Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas SILK's P/E ratio is -18.96. In terms of profitability, OWLT's ROE is -0.50%, compared to SILK's ROE of -0.35%. Regarding short-term risk, OWLT is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
OWLT vs FNA Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas FNA's P/E ratio is -19.83. In terms of profitability, OWLT's ROE is -0.50%, compared to FNA's ROE of -0.35%. Regarding short-term risk, OWLT is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check FNA's competition here
Enovis Corporation (NYSE: ENOV)
OWLT vs ENOV Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while ENOV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas ENOV's P/E ratio is 5.44. In terms of profitability, OWLT's ROE is -0.50%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, OWLT is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check ENOV's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
OWLT vs PRCT Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, PRCT has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while PRCT trades at $19.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas PRCT's P/E ratio is -9.85. In terms of profitability, OWLT's ROE is -0.50%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, OWLT is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check PRCT's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
OWLT vs IART Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, IART has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while IART trades at $13.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas IART's P/E ratio is 5.87. In terms of profitability, OWLT's ROE is -0.50%, compared to IART's ROE of -0.01%. Regarding short-term risk, OWLT is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
OWLT vs AORT Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, AORT has a market cap of 1B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while AORT trades at $21.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas AORT's P/E ratio is 35.64. In terms of profitability, OWLT's ROE is -0.50%, compared to AORT's ROE of -0.01%. Regarding short-term risk, OWLT is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check AORT's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
OWLT vs LMRI Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, LMRI has a market cap of 1B. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while LMRI trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas LMRI's P/E ratio is -20.64. In terms of profitability, OWLT's ROE is -0.50%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, OWLT is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check LMRI's competition here
CeriBell, Inc. (NASDAQ: CBLL)
OWLT vs CBLL Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, CBLL has a market cap of 991.8M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while CBLL trades at $26.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas CBLL's P/E ratio is -14.85. In terms of profitability, OWLT's ROE is -0.50%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, OWLT is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check CBLL's competition here
Bioventus Inc. (NASDAQ: BVS)
OWLT vs BVS Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, BVS has a market cap of 918.7M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while BVS trades at $13.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas BVS's P/E ratio is 17.84. In terms of profitability, OWLT's ROE is -0.50%, compared to BVS's ROE of +0.28%. Regarding short-term risk, OWLT is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check BVS's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
OWLT vs SIBN Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, SIBN has a market cap of 872.8M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while SIBN trades at $19.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas SIBN's P/E ratio is -57.88. In terms of profitability, OWLT's ROE is -0.50%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, OWLT is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SIBN's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
OWLT vs AHCO Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, AHCO has a market cap of 861.2M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while AHCO trades at $6.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas AHCO's P/E ratio is 12.92. In terms of profitability, OWLT's ROE is -0.50%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, OWLT is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check AHCO's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
OWLT vs CSII Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas CSII's P/E ratio is -20.83. In terms of profitability, OWLT's ROE is -0.50%, compared to CSII's ROE of -0.14%. Regarding short-term risk, OWLT is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CSII's competition here
InMode Ltd. (NASDAQ: INMD)
OWLT vs INMD Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, INMD has a market cap of 822.3M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while INMD trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas INMD's P/E ratio is 9.93. In terms of profitability, OWLT's ROE is -0.50%, compared to INMD's ROE of +0.12%. Regarding short-term risk, OWLT is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check INMD's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
OWLT vs BBNX Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, BBNX has a market cap of 795.9M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while BBNX trades at $17.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas BBNX's P/E ratio is -10.72. In terms of profitability, OWLT's ROE is -0.50%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, OWLT is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check BBNX's competition here
Varex Imaging Corporation (NASDAQ: VREX)
OWLT vs VREX Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, VREX has a market cap of 777.6M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while VREX trades at $18.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas VREX's P/E ratio is 19.44. In terms of profitability, OWLT's ROE is -0.50%, compared to VREX's ROE of +0.05%. Regarding short-term risk, OWLT is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check VREX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
OWLT vs CTKB Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, CTKB has a market cap of 690.9M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while CTKB trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas CTKB's P/E ratio is -28.34. In terms of profitability, OWLT's ROE is -0.50%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, OWLT is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check CTKB's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
OWLT vs PACB Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, PACB has a market cap of 636.7M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while PACB trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas PACB's P/E ratio is -5.00. In terms of profitability, OWLT's ROE is -0.50%, compared to PACB's ROE of -49.62%. Regarding short-term risk, OWLT is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check PACB's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
OWLT vs AVR Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, AVR has a market cap of 627.1M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while AVR trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas AVR's P/E ratio is -3.32. In terms of profitability, OWLT's ROE is -0.50%, compared to AVR's ROE of -0.78%. Regarding short-term risk, OWLT is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check AVR's competition here
Surmodics, Inc. (NASDAQ: SRDX)
OWLT vs SRDX Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas SRDX's P/E ratio is -34.66. In terms of profitability, OWLT's ROE is -0.50%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, OWLT is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SRDX's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
OWLT vs APEN Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas APEN's P/E ratio is -9.43. In terms of profitability, OWLT's ROE is -0.50%, compared to APEN's ROE of -0.85%. Regarding short-term risk, OWLT is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check APEN's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
OWLT vs KIDS Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, KIDS has a market cap of 563.3M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while KIDS trades at $21.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas KIDS's P/E ratio is -18.58. In terms of profitability, OWLT's ROE is -0.50%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, OWLT is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check KIDS's competition here
ZimVie Inc. (NASDAQ: ZIMV)
OWLT vs ZIMV Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, OWLT's ROE is -0.50%, compared to ZIMV's ROE of -0.07%. Regarding short-term risk, OWLT is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ZIMV's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
OWLT vs DCTH Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, DCTH has a market cap of 528.9M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while DCTH trades at $15.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas DCTH's P/E ratio is 1532.00. In terms of profitability, OWLT's ROE is -0.50%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, OWLT is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check DCTH's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
OWLT vs SSII Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, SSII has a market cap of 510.3M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while SSII trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas SSII's P/E ratio is -42.50. In terms of profitability, OWLT's ROE is -0.50%, compared to SSII's ROE of -0.27%. Regarding short-term risk, OWLT is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check SSII's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
OWLT vs TCMD Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, TCMD has a market cap of 503.2M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while TCMD trades at $22.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas TCMD's P/E ratio is 20.66. In terms of profitability, OWLT's ROE is -0.50%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, OWLT is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check TCMD's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
OWLT vs SGHT Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, SGHT has a market cap of 456.5M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while SGHT trades at $8.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas SGHT's P/E ratio is -14.98. In terms of profitability, OWLT's ROE is -0.50%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, OWLT is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check SGHT's competition here
Cerus Corporation (NASDAQ: CERS)
OWLT vs CERS Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, CERS has a market cap of 455.4M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while CERS trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas CERS's P/E ratio is -75.08. In terms of profitability, OWLT's ROE is -0.50%, compared to CERS's ROE of -0.10%. Regarding short-term risk, OWLT is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
OWLT vs NPCE Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, NPCE has a market cap of 432.3M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while NPCE trades at $12.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas NPCE's P/E ratio is -22.25. In terms of profitability, OWLT's ROE is -0.50%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, OWLT is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check NPCE's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
OWLT vs OFIX Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, OFIX has a market cap of 374.3M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while OFIX trades at $9.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas OFIX's P/E ratio is -6.03. In terms of profitability, OWLT's ROE is -0.50%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, OWLT is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check OFIX's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
OWLT vs SENS Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, SENS has a market cap of 372.8M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while SENS trades at $8.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas SENS's P/E ratio is -4.00. In terms of profitability, OWLT's ROE is -0.50%, compared to SENS's ROE of -1.66%. Regarding short-term risk, OWLT is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check SENS's competition here
CapsoVision, Inc. (NASDAQ: CV)
OWLT vs CV Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, CV has a market cap of 338.8M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while CV trades at $6.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas CV's P/E ratio is -10.76. In terms of profitability, OWLT's ROE is -0.50%, compared to CV's ROE of -1.78%. Regarding short-term risk, OWLT is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CV's competition here
Avita Medical Inc. (NASDAQ: RCEL)
OWLT vs RCEL Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, RCEL has a market cap of 331.9M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while RCEL trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas RCEL's P/E ratio is -9.28. In terms of profitability, OWLT's ROE is -0.50%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, OWLT is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check RCEL's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
OWLT vs SMLR Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas SMLR's P/E ratio is 3.92. In terms of profitability, OWLT's ROE is -0.50%, compared to SMLR's ROE of +0.20%. Regarding short-term risk, OWLT is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SMLR's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
OWLT vs CLPT Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, CLPT has a market cap of 294.2M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while CLPT trades at $9.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas CLPT's P/E ratio is -8.31. In terms of profitability, OWLT's ROE is -0.50%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, OWLT is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check CLPT's competition here
Quantum-Si incorporated (NASDAQ: QSI)
OWLT vs QSI Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, QSI has a market cap of 278.9M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while QSI trades at $1.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas QSI's P/E ratio is -3.07. In terms of profitability, OWLT's ROE is -0.50%, compared to QSI's ROE of -0.47%. Regarding short-term risk, OWLT is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check QSI's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
OWLT vs INFU Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, INFU has a market cap of 272M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while INFU trades at $13.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas INFU's P/E ratio is 32.88. In terms of profitability, OWLT's ROE is -0.50%, compared to INFU's ROE of +0.15%. Regarding short-term risk, OWLT is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check INFU's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
OWLT vs TMCI Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, TMCI has a market cap of 266M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while TMCI trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas TMCI's P/E ratio is -4.36. In terms of profitability, OWLT's ROE is -0.50%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, OWLT is more volatile compared to TMCI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check TMCI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
OWLT vs CATX Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, CATX has a market cap of 257.2M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while CATX trades at $2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas CATX's P/E ratio is -1.70. In terms of profitability, OWLT's ROE is -0.50%, compared to CATX's ROE of -0.42%. Regarding short-term risk, OWLT is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check CATX's competition here
Profound Medical Corp. (NASDAQ: PROF)
OWLT vs PROF Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, PROF has a market cap of 254.7M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while PROF trades at $7.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas PROF's P/E ratio is -7.15. In terms of profitability, OWLT's ROE is -0.50%, compared to PROF's ROE of -0.56%. Regarding short-term risk, OWLT is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check PROF's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
OWLT vs TLSI Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, TLSI has a market cap of 246.3M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while TLSI trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas TLSI's P/E ratio is -2.38. In terms of profitability, OWLT's ROE is -0.50%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, OWLT is more volatile compared to TLSI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check TLSI's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
OWLT vs MGRM Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas MGRM's P/E ratio is -12.00. In terms of profitability, OWLT's ROE is -0.50%, compared to MGRM's ROE of -1.17%. Regarding short-term risk, OWLT is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
OWLT vs ELMD Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, ELMD has a market cap of 228.4M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while ELMD trades at $27.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas ELMD's P/E ratio is 21.05. In terms of profitability, OWLT's ROE is -0.50%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, OWLT is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
OWLT vs NVRO Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas NVRO's P/E ratio is -1.91. In terms of profitability, OWLT's ROE is -0.50%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, OWLT is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NVRO's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
OWLT vs BSGM Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas BSGM's P/E ratio is -5.81. In terms of profitability, OWLT's ROE is -0.50%, compared to BSGM's ROE of +6.96%. Regarding short-term risk, OWLT is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check BSGM's competition here
RxSight, Inc. (NASDAQ: RXST)
OWLT vs RXST Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, RXST has a market cap of 187.5M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while RXST trades at $4.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas RXST's P/E ratio is -4.01. In terms of profitability, OWLT's ROE is -0.50%, compared to RXST's ROE of -0.17%. Regarding short-term risk, OWLT is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check RXST's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
OWLT vs MDGS Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas MDGS's P/E ratio is -0.27. In terms of profitability, OWLT's ROE is -0.50%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, OWLT is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check MDGS's competition here
Inogen, Inc. (NASDAQ: INGN)
OWLT vs INGN Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, INGN has a market cap of 171.7M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while INGN trades at $6.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas INGN's P/E ratio is -6.97. In terms of profitability, OWLT's ROE is -0.50%, compared to INGN's ROE of -0.13%. Regarding short-term risk, OWLT is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check INGN's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
OWLT vs QIPT Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas QIPT's P/E ratio is -15.87. In terms of profitability, OWLT's ROE is -0.50%, compared to QIPT's ROE of -0.08%. Regarding short-term risk, OWLT is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check QIPT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
OWLT vs FOCL Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, FOCL has a market cap of 157.4M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while FOCL trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas FOCL's P/E ratio is -4.06. In terms of profitability, OWLT's ROE is -0.50%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, OWLT is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check FOCL's competition here
Quanterix Corporation (NASDAQ: QTRX)
OWLT vs QTRX Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, QTRX has a market cap of 148.4M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while QTRX trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas QTRX's P/E ratio is -1.24. In terms of profitability, OWLT's ROE is -0.50%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, OWLT is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check QTRX's competition here
Neuronetics, Inc. (NASDAQ: STIM)
OWLT vs STIM Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, STIM has a market cap of 138.5M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while STIM trades at $1.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas STIM's P/E ratio is -4.52. In terms of profitability, OWLT's ROE is -0.50%, compared to STIM's ROE of -1.51%. Regarding short-term risk, OWLT is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check STIM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
OWLT vs LUCD Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, LUCD has a market cap of 115.6M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while LUCD trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas LUCD's P/E ratio is -1.64. In terms of profitability, OWLT's ROE is -0.50%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, OWLT is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check LUCD's competition here
iCAD, Inc. (NASDAQ: ICAD)
OWLT vs ICAD Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas ICAD's P/E ratio is -20.37. In terms of profitability, OWLT's ROE is -0.50%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, OWLT is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
OWLT vs HJLI Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas HJLI's P/E ratio is N/A. In terms of profitability, OWLT's ROE is -0.50%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, OWLT is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check HJLI's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
OWLT vs ASXC Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas ASXC's P/E ratio is -1.12. In terms of profitability, OWLT's ROE is -0.50%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, OWLT is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ASXC's competition here
Neovasc Inc. (NASDAQ: NVCN)
OWLT vs NVCN Comparison October 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 83.6M. In comparison, NVCN has a market cap of 82.9M. Regarding current trading prices, OWLT is priced at $4.63 on the NYSE, while NVCN trades at $30.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -33.00, whereas NVCN's P/E ratio is -1.99. In terms of profitability, OWLT's ROE is -0.50%, compared to NVCN's ROE of -1.21%. Regarding short-term risk, OWLT is more volatile compared to NVCN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NVCN's competition here